Genetic Technology Alert. Universal Immune Stimulatory Peptide; Site Specific Immunomodulators to Cure Inflammatory Bowel Disease and Cancer; Drug Used to Treat Tumors Targets Cancer Stem Cells

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.

Table of Contents

Genetic Technology Alert. Universal Immune Stimulatory Peptide; Site Specific Immunomodulators to Cure Inflammatory Bowel Disease and Cancer; Drug Used to Treat Tumors Targets Cancer Stem CellsIn This Issue1. UNIVERSAL IMMUNE STIMULATORY PEPTIDE2. SITE SPECIFIC IMMUNOMODULATORS TO CURE INFLAMMATORY BOWEL DISEASE AND CANCER3. DRUG USED TO TREAT TUMORS TARGETS CANCER STEM CELLS4. SOME KEY PATENTS IN IMMUNOMODULATORS5. TECHVISION 2015




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Related Subscription

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.